Indian Journal of Critical Care Case Report

Register      Login

VOLUME 1 , ISSUE 2 ( September-October, 2022 ) > List of Articles


Trichosporon asahii Bloodstream Infection in an Immunocompetent Patient: A Rare Entity

Biswajit Nayak

Keywords : Bloodstream infection, Immunosuppressed, Trichosporon asahii

Citation Information : Nayak B. Trichosporon asahii Bloodstream Infection in an Immunocompetent Patient: A Rare Entity. 2022; 1 (2):35-36.

DOI: 10.5005/jp-journals-11006-0013

License: CC BY-NC 4.0

Published Online: 04-11-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Infection with non-Candida species like Trichosporon is an emerging cause of fungal infection. It often causes fatal, life-threatening infections in immunosuppressed patients. They may have a varied presentation depending on the patient's immune status, ranging from self-limiting cutaneous manifestation to pneumonia, meningitis, and disseminated bloodstream infection. They cause infection in neutropenic and critically ill patients on broad-spectrum antibiotics with invasive medical devices. Herein we are reporting a rare Trichosporon asahii bloodstream infection in a non-neutropenic critically ill patient.

PDF Share
  1. Manzella JP, Berman IJ, Kukrika MD. Trichosporon beigelii fungemia and cutaneous dissemination. Arch Dermatol 1982;118(5):343–345. DOI: 10.1001/archderm.1982.01650170057025
  2. Mathews MS, Prabhakar S. Chronic meningitis caused by Trichosporon beigelii in India. Mycoses 1995;38(3-4):125–126. DOI: 10.1111/j.1439-0507.1995.tb00034.x
  3. Reyes CV, Stanley MM, Rippon JW. Trichosporon beigelii endocarditis as a complication of peritoneovenous shunt. Hum Pathol 1985;16(8):857–859. DOI: 10.1016/s0046-8177(85)80262-8
  4. Krcmery Jr V, Mateicka F, Kunova A, et al. Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol. Support Care Cancer 1999;7(1):39–43. DOI: 10.1007/s005200050221
  5. Kontoyiannis DP, Torres HA, Chagua M, et al. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 2004;36(8):564–569. DOI: 10.1080/00365540410017563
  6. Fanfair RN, Heslop O, Etienne K, et al. Trichosporon asahii among intensive care unit patients at a medical center in Jamaica. Infect Control Hosp Epidemiol 2013;34(6):638–641. DOI: 10.1086/670633
  7. Li H, Guo M, Wang C, et al. Epidemiological study of Trichosporon asahii infections over the past 23 years. Epidemiol Infect 2020;148:e169. DOI: 10.1017/S0950268820001624
  8. Bhagawati G, Nandwani S, Singhal S. Awareness and practices regarding bio-medical waste management among health care workers in a tertiary care hospital in Delhi. Indian J Med Microbiol 2015;33(4):580–582. DOI: 10.4103/0255-0857.167323
  9. Bayramoglu G, Sonmez M, Tosun I, et al. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection 2008;36(1):68–70. DOI: 10.1007/s15010-007-6278-6
  10. Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, et al. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 2005;49(10):4026–4034. DOI: 10.1128/AAC.49.10.4026-4034.2005
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.